Can you get medical cannabis for OCD in the UK?

Obsessive-compulsive disorder has an unusually clear first-line treatment in the UK, and an unusually clear negative result from the one controlled study of cannabis. That makes this a short page with a straightforward answer.

The short answer

  • No cannabis-based product is licensed for OCD, and NICE does not recommend one.
  • The one controlled study found no significant benefit over placebo.
  • Expectation drove the result — people improved whether or not they received an active drug.
  • Exposure and response prevention therapy is the treatment with the strongest evidence.
  • Avoidance is the mechanism of OCD, and a drug that dampens anxiety can quietly reinforce it.

Is OCD treated with medical cannabis in the UK?

It is occasionally assessed privately, usually where OCD sits alongside severe anxiety. No cannabis-based product is licensed for OCD and NICE guidance does not include cannabis-based medicines among the treatments it recommends.

NICE recommends a stepped approach built around cognitive behavioural therapy including exposure and response prevention, with an SSRI where therapy alone is not enough. Access to that therapy is patchy, and long waits are a real reason people look elsewhere — but the therapy remains the treatment with by far the strongest evidence base.

What the evidence actually shows

There is one controlled human laboratory study. It compared cannabis containing THC, cannabis containing predominantly cannabidiol, and placebo in adults with OCD, and found no significant difference between the active conditions and placebo on obsessions or compulsions.

The study behind that paragraph

Kayser RR, Haney M, Raskin M, Arout C, Simpson HB. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: a human laboratory study. Depression and Anxiety. 2020;37(8):801-811. Participants reported reduced anxiety after all three conditions, including placebo, which the authors attributed to expectancy.

Read the paper →

That placebo finding is the most useful part of the study for a patient to know. People felt better after taking something they believed would help, regardless of what it was. Any uncontrolled report of cannabis helping OCD has to contend with that explanation first.

The wider systematic review of cannabinoids in mental disorders reached the same conclusion it did elsewhere: insufficient controlled evidence to support use.

What a specialist will want to see

Given a negative controlled study, a specialist assessing OCD is generally looking at whether something else is the real target — severe comorbid anxiety, for instance — rather than at OCD itself.

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

There is a mechanism-level concern specific to OCD. The disorder is maintained by avoidance: the compulsion relieves the distress, which teaches the brain to repeat it. Anything that reliably reduces distress in the moment can function as another compulsion.

That is not a theoretical worry. It is the reason exposure-based therapy deliberately does the opposite — sitting with the discomfort until it fades on its own. A specialist who understands OCD will be alert to a medicine becoming part of the ritual rather than a way out of it.

The usual cautions apply as well: a personal or family history of psychosis, unstable mental illness, pregnancy or breastfeeding will normally count against treatment, and THC can increase anxiety in some people rather than reduce it.

How medical cannabis is thought to help

Given a negative controlled study, any account of how cannabis-based medicines might act on OCD is necessarily general and should not be read as a reason to expect benefit. It is worth knowing chiefly so the placebo finding above makes sense.

The body has its own endocannabinoid system — a network of receptors and signalling molecules involved in regulating anxiety, the stress response, mood and sleep. Because OCD sits close to the anxiety disorders, that system is a reasonable thing for researchers to examine. THC and CBD interact with it in different ways: THC acts directly on cannabinoid receptors and is responsible for the intoxicating effects, while CBD works more indirectly and is not intoxicating. If you want the underlying biology rather than the condition-specific picture, the guides on the endocannabinoid system and THC and CBD set it out in plain terms.

What any of this reduces, at most, is anxiety in the moment — and in OCD, momentary relief of distress is part of the problem rather than the solution.

What treatment involves in practice

In the uncommon situation where a specialist does consider a monitored trial — usually because severe anxiety, rather than OCD itself, is the real target — treatment follows the cautious pattern used across this field: start low, increase slowly, and review often.

Unlicensed cannabis-based products are prescribed on a named-patient basis, which places responsibility for the decision and for informed consent with the specialist rather than with a manufacturer's licence. Treatment usually begins at a low dose and is titrated upwards gradually, so that any benefit and any side effects can be judged against small, deliberate changes. Most prescriptions take the form of an oil or capsule taken by mouth, or dried flower for vaporising; the two behave differently in how quickly they act and how long they last, which is covered in how cannabis-based medicines are taken and how long they take to work.

Follow-up reviews are where the specialist checks whether the treatment is genuinely helping, whether it is quietly becoming part of the ritual rather than a way out of it, and whether the dose needs adjusting — or whether it should be stopped. How a dose is set and changed is explained in how a dose is decided and adjusted, and the range of unwanted effects in side effects of cannabis-based medicines.

Questions worth asking your specialist

A good assessment is a two-way conversation. Whether or not treatment is offered, these are sensible questions to bring:

If a clinic is reluctant to answer these plainly, that tells you something in itself. The broader question of whether treatment fits your situation is covered in can medical cannabis treat my condition?

If you want to take this further

The useful next step is a proper assessment, not a longer reading list. Gather your diagnosis, the treatments you have already tried and what happened with each, and a current list of your medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If OCD is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Frequently asked questions

Can I get medical cannabis for OCD in the UK?

It is occasionally assessed privately, usually alongside severe anxiety, but nothing is licensed for OCD and NICE does not recommend it. The one controlled study found no significant benefit over placebo.

What did the OCD study find?

A human laboratory study compared THC-containing cannabis, predominantly cannabidiol cannabis and placebo in adults with OCD. There was no significant difference between them. Participants improved after all three, which the authors attributed to expectation.

What is the recommended treatment for OCD?

NICE recommends cognitive behavioural therapy including exposure and response prevention, with an SSRI where therapy alone is not sufficient. That remains the treatment with the strongest evidence.

Could it make OCD worse?

It might. OCD is maintained by avoidance of distress, so anything that reliably removes distress in the moment risks becoming another compulsion. A specialist who understands OCD will weigh that carefully.

How is medical cannabis usually taken?

Most prescriptions are either an oil or capsule taken by mouth, or dried flower for vaporising. Oils and capsules tend to act more slowly and last longer, while vaporised flower acts faster and wears off sooner. Your specialist decides the format and starting dose with you, and treatment usually begins at a low dose and is increased slowly.

How long before I know if it is working?

There is no fixed answer, and judging it is one of the things a follow-up review is for. Because treatment starts low and is titrated slowly, a fair trial is measured in weeks rather than days. If it is not helping, or if side effects outweigh any benefit, a specialist should stop it rather than persist.

Can I stop taking it whenever I want?

Not without discussing it first. Regular THC use can lead to dependence, and stopping abruptly can cause irritability, poor sleep and restlessness that are easily mistaken for the original problem returning. If you decide to stop, a specialist can help you reduce the dose gradually.

Will it affect my driving or my job?

It can. It is an offence to drive while impaired, and cannabis-based medicines can affect concentration and reaction time. Some employers also operate their own drug and alcohol policies. It is worth understanding both before you start, rather than after.

Sources and further reading

Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.

  1. Kayser RR, et al. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: a human laboratory study. Depression and Anxiety (2020)
  2. Black N, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry (2019)
  3. NICE guideline CG31: Obsessive-compulsive disorder and body dysmorphic disorder
  4. NICE guideline NG144: Cannabis-based medicinal products
  5. NHS: Medical cannabis (and cannabis oils)
  6. MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use

Patient guide · Written by the Flora House editorial team · Last reviewed: 2 November 2026